• Record net profit of AED 280.8 million in FY-2021, a twenty-eight fold increase year-on-year
• Executed 4 transactions worth AED 1.7 billion demonstrating successful delivery of strategic priorities
• Highest recommended dividend payout* to date of AED 150 million for FY-2021, equating to 53% of profit attributable to equity holders or 6% of the Company’s share capital

14 February 2022 | Dubai | Amanat Holdings PJSC (“Amanat” or the “Company”), the GCC’s largest healthcare and education investment company, announces record financial results for the year ended 31 December 2021.

The Company recorded total income of AED
367.0 million, a significant five-fold increase on the AED 70.6 million recorded last year. Strong total income growth translated through to Amanat’s bottom-line, with the Company reporting record net profit of AED 280.8 million, a twenty-eight fold increase from the AED 10.1 million reported in FY-2020.

As a reflection of the record performance, Amanat has recommended the highest dividend payout to-date of AED 150 million for which the Board of Directors will be seeking shareholders’ approval in the Company’s upcoming General Assembly Meeting.

Commenting on this year’s performance, Amanat’s Chairman, Hamad Abdulla Alshamsi said:

“2021 was a transformative year which saw us deliver impressive growth, record profitability, and solid progress on our longer-term value creation strategy. The year’s results set a strong foundation for the future of Amanat, demonstrating the underlying strength of our chosen industries and investments, and the effectiveness of our corporate strategy”

“As a testament to our commitment to delivering sustainable value to our shareholders, we are pleased to mark this year with a significant increase in total shareholder returns (“TSR”) of c. AED1 billion derived from share price appreciation and our exceptional dividend recommendation* for the year”

“Looking ahead, alongside enhancing our current portfolio’s performance and optimizing our capital structure, we will look to invest in yielding assets, grow them into market leaders and build IPO-ready platforms.”

Consolidated Performance

Bottom-line profitability was boosted by Amanat’s successful divestment of its minority stakes in Taaleem Holdings and International Medical Center KSA, generating a gain on sale of AED
202.9 million and cash proceeds of AED 783 million.

Adjusting for the gain and trading impact of the two exits, Amanat recorded adjusted net profit of AED
103.4 million, a four-fold increase versus FY-2020, and demonstrating the underlying potential of Amanat’s investments and the resilience of its chosen industries.

Net profit was supported by continued cost saving and optimization efforts at the corporate level which saw holding level costs decline 25% year- on-year. Nonetheless, the Company started to grow its team towards the end of FY-2021 reflective of a growing portfolio of assets.

1 Includes share of results from associates, net profit from subsidiaries & Finance Lease income excluding NCI, PPA amortization and excludes share of results from divested associates.

2 Assets under Amanat’s education platform have a fiscal year ending on the 31st of August and thus Amanat’s consolidated results for the twelve months ended 31 December 2021 reflect eight months results from the education platform’s fiscal year ended 31 August 2021 in addition to 4 months from 2021/2022 fiscal year.

3 Includes share of results from associates, net profit from subsidiaries, finance income, interest & other operating income excluding NCI.